Table 1 General characteristics and comorbiditieas of the patients

Mean age (year) ± SD, (min.-max.)

36,80 ± 11,14 (18–64)

51,58 ± 8,75 (29–68)

0,000^a

Mean BMI (kg/m2) ± SD, (min.-max.)

45,64 ± 7,24 (34,4–79,6)

46,43 ± 7,67 (35,8–62,2)

0,569^a

Operation duration (dk) ± SD, ( min.-max.)

106,86 ± 40,58 (20–240)

107,13 ± 34,10 (60–180)

0,829^a

Hospitalization duration (day) ± SD, ( min.-max.)

4,71 ± 1,92 (3–36)

6,38 ± 3,32 (3–20)

0,000^a

Gender, n (%)

0,220^b

Female

379 (73,4)

36 (80,0)

Male

137 (26,6)

9 (20,0)

Follow-up Duration(Mounth) n(%)

0,005^b

Early Period (0–24)

209 (40,5)

17 (37,8)

Middle Period (25–60)

223 (43,2)

28 (62,2)

Late Period (61+)

84 (16,3)

-

ASA Scores n(%)

0,000^b

ASA-1

467 (90,5)

30 (66,7)

ASA-2

41 (7,9)

14 (31,1)

ASA-3

8 (1,6)

1 (2,2)

Diseases n(%)

DM

166 (32,2)

38 (84,4)

0,000^b

HT

130 (25,2)

25 (55,6)

0,000^b

HL/DL

107 (20,8)

17 (37,8)

0,010^b

OSAS

42 (8,1)

10 (22,2)

0,005^b

Hypothyroidism

78 (15,1)

9 (20,0)

0,251^b